| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |